A Centers for Disease Control and Prevention committee voted 14-0-1 in favor of recommending that Pfizer Inc.’s COVID-19 vaccine can be safely used in 12- to 15-year-olds. The recommendation, made Wednesday by the CDC’s Advisory Committee on Immunization Practices, follows a similar regulatory pathway as the original emergency-use authorization awarded in December. The expanded authorization for this age group was announced Monday by the Food and Drug Administration, the CDC committee voted Wednesday, and CDC director Dr. Rochelle Walensky signed off on the recommendation later that night. More than 60 million people in the U.S. have been immunized with the two-dose, mRNA vaccine developed by Pfizer and BioNTech SE , according to the latest CDC data.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.